Development and validation of a nomogram for predicting immune‐related pneumonitis after sintilimab treatment

Bibliographic Details
Main Authors:	Baohui Hong, Rong Chen, Caiyun Zheng, Maobai Liu, Jing Yang
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Construction and validation of “WCH‐nomogram” for predicting the prognosis after resection of colorectal liver metastases
by: Chuang Jiang, et al.
Published: (2024)

Developing and validating a nomogram for penile cancer survival: A comprehensive study based on SEER and Chinese data
by: Jiawen Luo, et al.
Published: (2024)

A novel nomogram based on inflammation biomarkers for predicting radiation cystitis in patients with local advanced cervical cancer
by: Jie Lin, et al.
Published: (2024)

Correction to “Development and internal validation of a nomogram based on peripheral blood inflammatory markers for predicting prognosis in nasopharyngeal carcinoma”LaiJ, LinP, ZhuangJ, XieZ., ZhouH., YangD., ChenZ., JiangD., HuangJ.Development and internal validation of a nomogram based on peripheral blood inflammatory markers for predicting prognosis in nasopharyngeal carcinoma. Cancer Med.2024; 13:e7135. doi:10.1002/cam4.7135
Published: (2024)

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy
by: Yuguang Zhao, et al.
Published: (2024)

Do additional nomograms based on the SEER dataset truly enhance survival prediction for patients with penile cancer?
by: Matthias May, et al.
Published: (2024)

Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan‐cancer analysis
by: Ming Li, et al.
Published: (2024)

Incidence and risk factors of immune‐related adverse events induced by immune checkpoint inhibitors among older adults with non‐small cell lung cancer
by: Yiran Rong, et al.
Published: (2024)

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors
by: Yuan Meng, et al.
Published: (2024)

Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study
by: Tianrui Feng, et al.
Published: (2024)

A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis
by: Ru Ma, et al.
Published: (2024)

Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy
by: Sha She, et al.
Published: (2024)

Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer
by: Alberto Mendoza‐Valderrey, et al.
Published: (2024)

Magnetic resonance imaging‐based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high‐risk non‐metastatic prostate cancer
by: Xiao‐Hui Wu, et al.
Published: (2024)

Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables
by: Yang Tan, et al.
Published: (2024)

Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
by: Zhan Yang, et al.
Published: (2024)

Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall
by: Madhumeeta Chadha, et al.
Published: (2024)

A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3‐rearranged renal cell carcinoma
by: Pengju Li, et al.
Published: (2024)

PriorClinico‐RadiologicalFeatures InformedMulti‐Modal MRImages Convolution Neural Network: A novel deep learning framework for prediction of lymphovascular invasion in breast cancer
by: Hong Zheng, et al.
Published: (2024)

Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer
by: Yuxuan Hao, et al.
Published: (2024)

An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes
by: Linyong Zheng, et al.
Published: (2024)

Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI ‐related distress scale ( MRI ‐ DS )
by: Danbee Kang, et al.
Published: (2024)

Development and validation of a hierarchical approach for lymphoma classification using immunohistochemical markers
by: Jiming Xu, et al.
Published: (2024)

Correction to Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI ‐related distress scale ( MRI ‐ DS )
Published: (2024)

phi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese population
by: Ruofan Shi, et al.
Published: (2024)

Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors
by: Elina Kaprio, et al.
Published: (2024)

Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma
by: Angela E. Alnemri, et al.
Published: (2024)

Impact of immune‐related adverse events on survival outcomes in extensive‐stage small cell lung cancer patients treated with immune checkpoint inhibitors
by: Tadashi Nishimura, et al.
Published: (2024)

Construction and validation of machine learning models for predicting distant metastases in newly diagnosed colorectal cancer patients: A large‐scale and real‐world cohort study
by: Ran Wei, et al.
Published: (2024)

The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
by: Yongmei Wu, et al.
Published: (2025)

Lymphocyte activation markers predict the therapeutic response to immune checkpoint inhibitors: A case–control study
by: Takuya Iwamoto, et al.
Published: (2024)

Artificial neural network identified a 20‐gene panel in predicting immunotherapy response and survival benefits after anti‐PD1/PD‐L1 treatment in glioblastoma patients
by: Yaning Wang, et al.
Published: (2024)

Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study
by: Yi Zheng, et al.
Published: (2024)

Identification ofPSMD11as a novel cuproptosis‐ and immune‐related prognostic biomarker promoting lung adenocarcinoma progression
by: Qiumin Huang, et al.
Published: (2024)

A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection
by: Qu Xie, et al.
Published: (2024)

Development and Validation of an AI ‐Assisted Predictive Model Integrating R2 * Mapping and Clinical Indicators for Clinically Significant Prostate Cancer
by: Xin Li, et al.
Published: (2026)

Prognostic significance of systemic immune‐inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection
by: Guanhua Chen, et al.
Published: (2024)

Analysis of the clinical efficacy and safety of anti‐PD‐1 immune checkpoint inhibitors in locally advanced nasopharyngeal cancer
by: Shuling Shi, et al.
Published: (2024)

Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor
by: Guiming Deng, et al.
Published: (2024)

Improving access to cancer care among rural populations in India: Development of a validated tool for health system capacity assessment
by: Meritxell Mallafré‐Larrosa, et al.
Published: (2024)

Similar Items

Similar Items